norfluoxetine has been researched along with gamma-aminobutyric acid in 2 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drafts, BC; Fisher, JL; Robinson, RT | 1 |
| Costa, E; Guidotti, A; Pinna, G | 1 |
1 review(s) available for norfluoxetine and gamma-aminobutyric acid
| Article | Year |
|---|---|
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake.
Topics: Animals; Brain; Fluoxetine; gamma-Aminobutyric Acid; Humans; Mental Disorders; Mood Disorders; Pregnanolone; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Social Isolation; Synaptic Transmission | 2009 |
1 other study(ies) available for norfluoxetine and gamma-aminobutyric acid
| Article | Year |
|---|---|
Fluoxetine increases GABA(A) receptor activity through a novel modulatory site.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; gamma-Aminobutyric Acid; Mammals; Receptors, GABA-A; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors | 2003 |